Press release
Prominent AI In Genomics Market Trend for 2025: AI-Driven Solution Revolutionizing High-Resolution Analysis In The AI In Genomics Market
Prominent AI In Genomics Market Trend
The expansion of the AI in genomics market is likely to be fuelled by the rising implementation of AI. Artificial intelligence, a field that leverages computer science and significant datasets to address challenges, encompasses machine learning and deep learning, often discussed within the realm of artificial intelligence. AI's role in genomics extends to detecting genetic diseases and identifying the predominant cancer type, predicting disease progression in patients, pinpointing genomic variations that cause diseases, and enhancing the performance of gene editing tools. Such advantages have led to an increasing demand for AI in genomics. To illustrate, a report published by the US technology corporation, International Business Machines Corporation (IBM), in May 2022 revealed a dramatic spike in the worldwide AI adoption rate, reaching 35%, a four percent increase from the year before. Moreover, a report released by the Australian government agency, the Commonwealth Scientific and Industrial Research Organization (CSIRO), in May 2023 indicated that 68% of Australian businesses have incorporated artificial intelligence technologies, and an extra 23% plan to do so over the forthcoming year. As such, the escalating adoption of AI acts as a catalyst for the AI in genomics market's growth.
Get Your AI In Genomics Market Report Here:
https://www.thebusinessresearchcompany.com/report/ai-in-genomics-global-market-report
What Is the projected market size and growth rate for the ai in genomics market?
The market size for AI in genomics has seen a dramatic increase in recent times. The value is forecasted to rise from $1.06 billion in 2024 to $1.52 billion in 2025, depicting a compound annual growth rate (CAGR) of 42.8%. Progress in genomic sequencing, coping mechanisms for data handling, demand for personalized medicine, enhancement in disease comprehension and diagnosis, as well as advancements in drug discovery and development, have all contributed to the growth during the historical period.
In the ensuing years, the AI in genomics market is predicted to experience profound growth. The market is set to expand to $6.64 billion by 2029 at a compound annual growth rate (CAGR) of 44.6%. The heightened expansion anticipated during the forecast period can be traced back to the proliferation of genomic databases, improved genomic data protection, AI-incited discovery of biomarkers, consolidation with other 'omics' data, and increased patient engagement and education. The striking trends expected during the forecast timeline encompass the use of AI in cancer genomics, AI-led enhancements in genomic imaging, AI-orchestrated biomarker discovery, integration of genomic data across medical systems, and the application of AI in functional genomics research.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9612&type=smp
What new trends are reshaping the ai in genomics market and its opportunities?
Progress in technology is becoming a significant trend in the AI in genomics industry. Most prime businesses in this market are concentrating on creating cutting-edge technological solutions to enhance their market status. For instance, Genomic Vision, a biotechnology firm from France that primarily deals in the development of diagnostic applications for genetic disorders and cancers, debuted an AI-based software named FiberSmart, in March 2023. This tool promotes high-resolution visualization and analysis of long strands of DNA. It carries the potential to revolutionize the detection and cure of genetic diseases. Its inception aimed at elevating the accuracy and efficacy of genetic disease diagnosis and therapy. Large data volumes are evaluated using this technology to discover patterns and insights that human analysis would fail to identify.
What major market segments define the scope and growth of the ai in genomics market?
The AI in genomics market covered in this report is segmented -
1) By Component: Hardware, Software, Services
2) By Technology: Machine Learning, Computer Vision
3) By Functionality: Genome Sequencing, Gene Editing, Other Functionalities
4) By Application: Drug Discovery And Development, Precision Medicine, Diagnostics, Other Applications
5) By End-Use: Pharmaceutical And Biotech Companies, Healthcare Providers, Research Centers, Other End-Users
Subsegments:
1) By Hardware: Servers, Storage Devices, Networking Equipment
2) By Software: Data Analysis Software, Machine Learning Algorithms, Visualization Tools, Genomic Data Management Software
3) By Services: Consulting Services, Integration Services, Support And Maintenance, Data Analytics Services
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9612
Which region dominates the ai in genomics market?
North America was the largest region in the AI in genomics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the AI in the genomics market report during the forecast period. The regions covered in the AI in genomics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Which key market leaders are driving the ai in genomics industry growth?
Major companies operating in the AI in genomics market include International Business Machines Corporation, Microsoft Corp., NVIDIA Corporation, Deep Genomics Inc., BenevolentAI Ltd., Fabric Genomics Inc., Verge Genomic Inc., Freenome Holdings Inc., MolecularMatch Inc., SOPHiA GENETICS SA, Data4Cure Inc., PrecisionLife Ltd., Genoox Ltd., Lifebit Ltd., Empiric Logic Ltd., FDNA Inc., DNAnexus Inc., Engine Biosciences Pte Ltd., 4baseCare, Congenica Ltd., CytoReason Ltd., Emedgene Technologies LTD, Illumina Inc., Lifebit Biotech Ltd., Mendel.ai, Predictive Oncology Inc., Tempus Labs Inc., 10x Genomics Inc., Repositive Limited, Genedata AG, Global Gene Corp, Nference Inc., Bluebee Holding B.V., Genomenon Inc.
Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=9612&type=smp
What Is Covered In The AI In Genomics Global Market Report?
• Market Size Forecast: Examine the ai in genomics market size across key regions, countries, product categories, and applications.
• Segmentation Insights: Identify and classify subsegments within the ai in genomics market for a structured understanding.
• Key Players Overview: Analyze major players in the ai in genomics market, including their market value, share, and competitive positioning.
• Growth Trends Exploration: Assess individual growth patterns and future opportunities in the ai in genomics market.
• Segment Contributions: Evaluate how different segments drive overall growth in the ai in genomics market.
• Growth Factors: Highlight key drivers and opportunities influencing the expansion of the ai in genomics market.
• Industry Challenges: Identify potential risks and obstacles affecting the ai in genomics market.
• Competitive Landscape: Review strategic developments in the ai in genomics market, including expansions, agreements, and new product launches.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Prominent AI In Genomics Market Trend for 2025: AI-Driven Solution Revolutionizing High-Resolution Analysis In The AI In Genomics Market here
News-ID: 3893518 • Views: …
More Releases from The Business research company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Genomic
Genomic Cancer Testing Market Insights on the Impact of Genomic Profiling and Bi …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Genomic Cancer Testing Market - (By Test Type (Genomic Profiling Tests, Liquid Biopsy Tests, Companion Diagnostic Tests, Pharmacogenomic Tests, Hereditary Cancer Tests, Other specialized genomic tests), By Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Ovarian Cancer, Melanoma, Leukemia, Lymphoma, Other specific cancer types), By Technology (Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR),…
Japan Genomic Medicine Market 2025 | Hospitals & clinics lead with 53% share, ad …
Leander, Texas and Tokyo, Japan - Nov.27.2025
As per DataM intelligence research report" Japan Genomic Medicine Market to expected to grow at High CAGR during forecast period 2024-2031." Personalized treatment approaches and advanced research investments are boosting genomic medicine adoption in Japan.
Download your exclusive sample report today: (corporate email gets priority access):
https://www.datamintelligence.com/download-sample/japan-genomic-medicine-market?Prasad
Japan: Recent Industry Developments
✅ In November 2025, Takeda Pharmaceutical advanced genomic-guided therapies for rare hereditary diseases, improving precision in…
Genomic and Epigenomic Profiling Market Development Driven by Investment in Biot …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Genomic & Epigenomic Profiling Market Size, Share & Trends Analysis Report, By Type (Genomic Profiling and Epigenomic Profiling), By Application (Clinical Diagnostics, Agriculture & Animal Research, and Drug Discovery & Development), By Technology (NGS, PCR-based, and Microarray), By End-use (Hospitals, Pharmaceuticals, and Research Institutes),-Market Outlook And Industry Analysis 2034"
Genomic & Epigenomic Profiling Market Size is…
Emerging Trends Influencing The Growth Of The Genomic Biomarker Market: Technolo …
The Genomic Biomarker Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
How Big Is the Genomic Biomarker Market Size Expected to Be by 2034?
The size of the genomic biomarker market has witnessed swift expansion in the recent past. It is slated to expand from a…
Genomic Biomarker Market Future Business Opportunities 2025-2032 | Liquid Genomi …
Latest Report, titled "Genomic Biomarker Market" Trends, Share, Size, Growth, Opportunity and Forecast 2025-2032, by Coherent Market Insights offers a comprehensive analysis of the industry, which comprises insights on the market analysis. The report also includes competitor and regional analysis, and contemporary advancements in the market.
The report features a comprehensive table of contents, figures, tables, and charts, as well as insightful analysis. The Genomic Biomarker market has been expanding significantly…
Lipid-Nanoparticle Based Genomic Medicines Market
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Lipid-Nanoparticle Based Genomic Medicines Market - (By Type (Liposome-based Nanoparticles, Micelle-based Nanoparticles, Lipid-Coated Nanoparticles), By Application (Cancer Treatment, Infectious Diseases, Genetic Disorders, Cardiovascular Diseases, Others), By Therapeutic Payload (mRNA-based Therapeutics, siRNA-based Therapeutics, miRNA-based Therapeutics, Other Genomic Medicines), By End-User (Hospitals, Biopharmaceutical Companies, Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the…
